Recently, several studies demonstrated that cancer cells carrying IDH mutations display some metabolic specificities, especially enhanced mitochondrial oxidative metabolism compared with wild-type cancer cells, and these cells tend to show vulnerability to mitochondrial inhibition (37–43). Here, IDH1 is linked to cancer.